医学
基因分型
宫颈癌
HPV感染
内科学
肿瘤科
人乳头瘤病毒
宫颈上皮内瘤变
中国人口
Ascus(苔藓虫)
队列
鳞状上皮内病变
阴道镜检查
作者
Wei Wang,Huina Zhang,Leqian Lin,Aimin Yang,Jing Yang,Weihong Zhao,Zhilian Wang,Lili Zhang,Xiaoqiang Su,Zhe Wang,Chen Wang,Haitao Zhang,Bo Feng,Dongyan Li,Huiqiang Liu,Xiaofen Niu,Jintao Wang,Jinghui Song,Li Li,Weiguo Lv,Chengquan Zhao,Min Hao
出处
期刊:Journal of Cancer
[Ivyspring International Publisher]
日期:2021-03-14
卷期号:12 (10): 2815-2824
被引量:1
摘要
Objective: In this prospective, population-based study, we evaluated the utility of high-risk human papillomavirus (HR-HPV) genotyping for triaging women with atypical squamous cells of undetermined significance (ASC-US) in the Chinese rural area. Methods: A total of 40,000 women were recruited from rural areas of Shanxi Province, China, between June 2014 and December 2014. Women with Pap results of ASC-US underwent HPV genotyping, colposcopy and histopathological examination. For those with normal cervixes or cervical intraepithelial neoplasia (CIN) 1 on the initial evaluation, a 2-year follow-up study was performed. Results: The reporting rate of ASC-US was 5.76% (2,304/40,000) in the study population. The detection rates of CIN 2 or above (CIN2+) and CIN 3 or above (CIN3+) in women with ASC-US were 7.28% and 1.75%, respectively. HPV 16 (39.53%), HPV 58 (17.83%), and HPV 52 (15.50%) were the three most prevalent HR-HPV genotypes among all women with ASC-US cytology. The five most common HR-HPV genotypes in CIN3+ lesions were HPV16, HPV58, HPV33, HPV31 and HPV18. Compared with the 15 HR-HPV testing, genotyping for a combination of HPV16/18/31/33/58 increased specificity significantly with virtually no loss of sensitivity for detecting CIN2+ and CIN3+ lesions, as well as significantly reduced colposcopy referral rate (23.15% vs 33.70%, p<0.01). In addition, in the 2-year follow-up period, women with infection of HPV16, 18, 31, 33 or 58 genotypes were the most likely population (92%, 23/25) to develop CIN2 lesion. Conclusion: Our results demonstrate that genotyping for a combination of HPV16/18/31/33/58 provides a more efficient and cost-effective model to risk-stratify women with ASC-US in the Chinese rural population.